COCP - Cocrystal Pharma, Inc.

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 2.1

Open

$ 1.85

Bid

$ 2.05 x 100

Ask

$ 2.11 x 100

Day's Range

$ 1.85 - $ 2.10

52 Week Range

$ 1.33 - $ 3.24

Volume

54,134

Average Volume

Market Cap

21.37M

Beta (5Y Monthly)

$ -0.21

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-28-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-29-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-11-2022	03-31-2022	10-Q
11	03-23-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-17-2021	03-31-2021	10-Q
15	03-17-2021	12-31-2020	10-K
16	11-13-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-13-2020	03-31-2020	10-Q
19	03-27-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	04-01-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-21-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-08-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-31-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-09-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	03-15-2016	12-31-2015	10-K
36	11-16-2015	09-30-2015	10-Q
37	08-14-2015	06-30-2015	10-Q
38	05-14-2015	03-31-2015	10-Q
39	03-31-2015	12-31-2014	10-K
40	11-14-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cocrystal Pharma To Highlight Near-term Cl...
08/19/2024 20:11:03

Cocrystal Pharma, Inc.'s (NASDAQ:COCP) management announces its participation in the upcoming Virtual Investor Summit Micro...

Cocrystal Pharma Q2 EPS $(0.53) Misses $(0...
08/14/2024 12:08:06

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(...

Cocrystal Pharma Reports Results From Sing...
07/18/2024 12:08:17

Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") today reported favorable safety and tolerab...

HC Wainwright & Co. Reiterates Buy on Cocr...
05/14/2024 10:25:21

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 pr...

Cocrystal Pharma Q1 2024 EPS $(0.39) Up Fr...
05/13/2024 12:04:35

Cocrystal Pharma Completes Enrollment Of 7...
05/01/2024 12:12:55

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

HC Wainwright & Co. Reiterates Buy on Cocr...
04/04/2024 10:24:22

HC Wainwright & Co. reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 price target.

Cocrystal Pharma Q4 EPS $(0.44) Beats $(0....
03/28/2024 15:14:42

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0....

Recap: Cocrystal Pharma Q4 Earnings
03/28/2024 13:50:06

HC Wainwright & Co. Reiterates Buy on Cocr...
03/20/2024 10:47:37

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $10 pr...

Cocrystal Pharma Receives Pre-IND Response...
03/19/2024 12:02:19

Feedback provides greater clarity on regulatory requirements for planned Phase 2b trialBOTHELL, Wash., March 19, 2024 (GLOBE NE...

Cocrystal Pharma Provides An Update On The...
01/04/2024 13:13:56

Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") provides an update on the clinical developm...

HC Wainwright & Co. Maintains Buy on Cocry...
01/03/2024 13:43:33

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cocrystal Pharma (NASDAQ:COCP) with a Buy and lowers the price ...

Cocrystal Pharma Received Notice From Merc...
12/21/2023 22:05:29

-8-K

Cocrystal Pharma Announces First-Patient-I...
12/06/2023 13:06:34

HC Wainwright & Co. Reiterates Buy on Cocr...
12/04/2023 11:59:15

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Cocrystal Pharma (NASDAQ:COCP) with a Buy and maintains $12 pr...

Cocrystal Pharma Announces The Presentatio...
11/29/2023 13:14:01

Cocrystal has initiated a Phase 2a human challenge trial with oral CC-42344 in the UK in subjects infected with influenza A, an...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
11/16/2023 21:31:07

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
11/15/2023 21:31:03